Search results
Results from the WOW.Com Content Network
Neurofibromatosis type 1: NF2 Neurofibromatosis type 2: NKH Nonketotic hyperglycinemia: NLD Nonverbal learning disability: NMDs Neuronal migration disorders: NMO Neuromyelitis optica: NMS Neuroleptic malignant syndrome: NP Niemann–Pick disease: NPC1 Niemann–Pick disease, type C1 NPH Normal pressure hydrocephalus: NTD Neural tube defect ...
Pronunciation follows convention outside the medical field, in which acronyms are generally pronounced as if they were a word (JAMA, SIDS), initialisms are generally pronounced as individual letters (DNA, SSRI), and abbreviations generally use the expansion (soln. = "solution", sup. = "superior").
Café au lait spot characteristic of NF1 Diagnostic criteria of neurofibromatosis type I, requiring at least 2 of the mentioned items. [6]The following is a list of conditions and complications associated with NF-1, and, where available, age range of onset and progressive development, occurrence percentage of NF-1 population, method of earliest diagnosis, and treatments and related medical ...
nerve conduction test, aka nerve conduction study: NCV: nerve conduction velocity (see nerve conduction study) ND (examination) not done NDI: nephrogenic diabetes insipidus NDSC: National Decision Support Company NE: norepinephrine: Ne: neutrophil granulocytes: NEAD: Non-epileptic attack disorder: NEAP: Net Endogenous Acid Production NEC: not ...
Neurofibromatosis arise from the supporting cells of the nervous system rather than the neurons themselves. [1] In NF1, the tumors are neurofibromas (tumors of the peripheral nerves), while in NF2 and schwannomatosis tumors of Schwann cells are more common. [1] Diagnosis is typically based on symptoms, examination, medical imaging, and biopsy.
This is a list of abbreviations used in medical prescriptions, including hospital orders (the patient-directed part of which is referred to as sig codes).This list does not include abbreviations for pharmaceuticals or drug name suffixes such as CD, CR, ER, XT (See Time release technology § List of abbreviations for those).
Instead, people with neurofibromatosis are followed by a team of specialists to manage symptoms or complications. [ 6 ] [ 32 ] However, in April, 2020, [ 33 ] the FDA approved selumetinib (brand name Koselugo) for the treatment of pediatric patients 2 years of age and older with neurofibromatosis type 1 (NF1) who have symptomatic, inoperable ...
The main discussion of these abbreviations in the context of drug prescriptions and other medical prescriptions is at List of abbreviations used in medical prescriptions. Some of these abbreviations are best not used, as marked and explained here.